Study identifies vulnerable groups least likely to have COVID-19 antibodies
Findings from the MELODY study have identified which people with compromised immune systems are less likely to have COVID-19 antibodies.
New centre established to help develop drug delivery and vaccine technologies
The Intracellular Drug Delivery Centre aims to develop new drug delivery technologies and support promising RNA vaccines and therapeutics.
MSD partners with Imperial to access insights for better health
Pharmaceutical company MSD has partnered with Imperial to reveal insights that will aid its mission to support clinicians and save and improve lives.
Delaying second doses of vaccine reduced COVID-19 hospitalisations and deaths
Delaying people’s second COVID-19 vaccine dose likely prevented tens of thousands of hospitalisations and thousands of deaths in England.
What Imperial research taught us about COVID-19 in 2022
From increased understanding of immunity to analysing the success of vaccines, we look back at what Imperial taught us about COVID-19 in 2022.
First-line defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline 9 months after infection, while those found in the blood last at least a year.
Prof. Faith Osier receives prestigious award for her contribution to Immunology
Only two awards were given by the British Society of Immunology (BSI) this year, and Professor Osier is one of recipients.
Feature
Covid won’t be the last pandemic – climate change will make sure of that
As the world warms, infectious diseases will spread – now’s the time to prepare, says Dr Ilaria Dorigatti.
Why do children need polio vaccine boosters - Q and A
On World Polio Day, we talk to two experts about why polio boosters are needed in London.
Infectious disease trailblazers inspire Great Exhibition Road Festival-goers
No stranger to trailblazers, the Department of Infectious Disease had a strong presence at the 2022 Great Exhibition Road Festival.
